Sanjay Nayak
Chief Strategy Officer at Ocular Therapeutix, Inc (OCUL)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $166K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 26SEC | OCULOcular Therapeutix, Inc | Sell Plan | 1,897326,898 held (−1%) | $10.78 | $20K | -30.1% |
| May 28SEC | OCULOcular Therapeutix, Inc | Sell Plan | 1,858328,795 held (−1%) | $8.20 | $15K | -8.0% |
| Feb 25SEC | OCULOcular Therapeutix, Inc | Sell Plan | 1,759330,653 held (−1%) | $8.28 | $15K | -8.9% |
| Feb 17SEC | OCULOcular Therapeutix, Inc | Sell Plan | 10,348332,412 held (−3%) | $9.04 | $94K | -16.6% |
| Nov 26SEC | OCULOcular Therapeutix, Inc | Sell Plan | 1,878277,860 held (−1%) | $12.04 | $23K | -37.4% |
- Sell
Chief Strategy Officer Sanjay Nayak sold $20K of OCUL at $10.78 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Strategy Officer Sanjay Nayak sold $15K of OCUL at $8.20 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Strategy Officer Sanjay Nayak sold $15K of OCUL at $8.28 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Strategy Officer Sanjay Nayak sold $94K of OCUL at $9.04 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Strategy Officer Sanjay Nayak sold $23K of OCUL at $12.04 — pre-scheduled 10b5-1 plan sale.